BNR — Burning Rock Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Burning Rock Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	20-F	20-F	20-F	6-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	411	2,263	1,497	908	615
Net Total Accounts Receivable
Net Total Receivables	209	147	158	170	150
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	707	2,524	1,821	1,259	884
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	89.3	111	406	300	144
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	848	2,663	2,279	1,587	1,040
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	164	242	372	411	263
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	212	242	433	429	272
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	636	2,421	1,845	1,158	768
Total Liabilities & Shareholders' Equity	848	2,663	2,279	1,587	1,040
Total Common Shares Outstanding